ArticleAntimicrobial agents and chemotherapy2013

Can inhibitor-resistant substitutions in the Mycobacterium tuberculosis β-Lactamase BlaC lead to clavulanate resistance?: a biochemical rationale for the use of β-lactam-β-lactamase inhibitor combinations.

Sebastian G Kurz et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.